종양 절제 세계 시장 규모는 2022년 14억 8,000만 달러로 평가되었고, 예측 기간(2024-2031) 동안 연평균 13.5%의 연평균 복합 성장률(CAGR)로 2023년 16억 8,000만 달러에서 2031년 46억 3,000만 달러로 성장할 것으로 예상됩니다.
암 발병률 증가와 안전한 치료 옵션에 대한 수요 증가가 시장 성장을 가속하는 주요 요인으로 작용하고 있습니다. 세계보건기구(WHO)는 2030년까지 전 세계적으로 매년 1,000만 명에서 1,100만 명의 암 환자가 새로 진단될 것으로 예상하고 있습니다. 저소득 국가에서는 신규 암 환자가 80% 이상 증가할 것으로 예상되는 반면, 고소득 국가에서는 40% 증가할 것으로 예상됩니다. 이러한 암 환자의 급증과 함께 저침습적, 비침습적 치료 옵션에 대한 강한 수요는 향후 몇 년동안 시장 규모를 크게 확대할 것으로 예상됩니다. 외과 의사와 환자 모두 최소침습적 치료법을 선호함에 따라 첨단 종양 절제에 대한 수요가 증가할 가능성이 높습니다. 이러한 기술은 빠른 회복, 환자 편의성 향상, 시술 시간 단축 등의 이점이 있습니다. 기존 치료법과는 달리, 첨단 절제술은 종종 외래에서 시행되기 때문에 입원할 필요가 없어 전반적인 의료 비용을 절감할 수 있습니다. 절제술은 특히 작은 종양에 효과적이며, 그 이용률은 암 발견률과 밀접한 관련이 있습니다. 그러나 2020년 코로나19 사태로 인해 검진 활동 감소로 인해 신규 암 진단이 크게 감소하면서 시장은 눈에 띄는 영향을 받았는데, Our World in Data의 조사에 따르면 암 진단의 70% 이상이 50세 이상에서 발생했으며, 이 수치는 고령화에 따라 증가할 것으로 예상됩니다. 증가할 것으로 예상됩니다. 노화로 인한 신체 기능 저하가 암 유병률을 증가시키기 때문에 비침습적 절제술에 대한 수요는 확대될 것으로 예상됩니다. 정확성, 기동성, 비용 효율성을 높이기 위한 기술 발전이 시장의 혁신을 촉진하고 있습니다. 외부에서 냉각된 프로브를 사용하여 병변의 크기를 개선하고 통증을 완화하는 냉각 방사선 소작술과 같은 새로운 기술은 향후 시장 확대에 중요한 역할을 할 것으로 예상됩니다.
Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).
The growing incidence of cancer and the increasing demand for safer therapeutic options are major factors fueling market growth. The World Health Organization (WHO) projects that by 2030, there will be between 10 to 11 million new cancer cases diagnosed globally each year. In low-income countries, new cancer cases are expected to rise by over 80%, compared to a 40% increase in high-income nations. This surge in cancer cases, combined with the strong desire for minimally and non-invasive treatment options, is anticipated to drive significant market expansion in the coming years. The preference for minimally invasive procedures among both surgeons and patients is likely to enhance the demand for advanced tumor ablation techniques. These methods offer advantages such as quicker recovery, improved patient comfort, and shorter procedure times. Unlike traditional treatments, advanced ablation procedures are often performed on an outpatient basis, eliminating the need for hospital admission and reducing overall healthcare costs. Ablation is particularly effective for small tumors, and its utilization is closely linked to cancer detection rates. However, the market experienced a notable impact in 2020, as the COVID-19 pandemic led to a significant reduction in new cancer diagnoses due to decreased screening activities. A survey by Our World in Data highlights that over 70% of cancer diagnoses occur in individuals over 50, a number expected to rise with the aging population. As age-related decline in bodily functions increases the prevalence of cancer, the demand for non-invasive ablation procedures is expected to grow. Technological advancements aimed at improving accuracy, mobility, and cost-effectiveness are driving market innovation. Emerging techniques, such as cooled radiofrequency ablation, which uses externally chilled probes to enhance lesion size and provide pain relief, are poised to play a significant role in the market's future expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Tumor Ablation Market Segmental Analysis
The global tumor ablation market is segmented by technology, application, treatment, and region. Based on technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, High-intensity-focused Ultrasound (HIFU), and other ablation technologies. Based on treatment, the market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. Based on application, the market is segmented into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers. Based on end users, the market is segmented into Hospitals & Clinics, Cancer Care Centers, and other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Tumor Ablation Market
The increasing global incidence of cancer, especially lung, liver, kidney, and breast cancers, is significantly driving the growth of the tumor ablation market. Tumor ablation techniques are gaining prominence as they provide minimally invasive alternatives to traditional surgery, offering effective treatment options for localized tumors. These methods are particularly valuable for patients who may not be eligible for conventional surgical procedures. By offering less invasive treatment options, tumor ablation techniques address a critical need in the oncology field. They present a viable solution for patients with localized tumors, allowing for effective management of cancer while minimizing the risks and recovery times associated with more invasive surgical interventions.
Restraints in the Global Tumor Ablation Market
Tumor ablation procedures can be costly, particularly when advanced technologies and imaging guidance are used. The high expenses associated with specialized equipment, consumables, and skilled healthcare professionals can restrict access to these treatments, especially in resource-limited regions and developing countries. The financial burden of these procedures can limit their availability and make them less accessible to patients in areas with constrained healthcare resources. This cost factor poses a significant challenge to the widespread adoption of tumor ablation techniques across diverse healthcare settings.
Market Trends of the Global Tumor Ablation Market
The tumor ablation market is experiencing ongoing technological progress, resulting in the emergence of more sophisticated and precise ablation techniques. Innovations include the incorporation of imaging technologies for real-time guidance, the application of robotic systems to boost precision, and the introduction of novel energy sources for ablation. These advancements contribute to improved efficacy and safety in tumor ablation procedures. As technology continues to evolve, these developments are significantly enhancing the effectiveness of tumor ablation treatments. The integration of advanced imaging and robotic systems, along with new energy modalities, ensures greater accuracy and safety during procedures, thereby improving overall patient outcomes.